Near-Infrared Fluorescence Imaging for Noninvasive Trafficking of Scaffold Degradation by Kim, Soon Hee et al.
 
Near-Infrared Fluorescence Imaging for Noninvasive Trafficking
of Scaffold Degradation
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Kim, Soon Hee, Jeong Heon Lee, Hoon Hyun, Yoshitomo
Ashitate, GwangLi Park, Kyle Robichaud, Elaine Lunsford,
Sang Jin Lee, Gilson Khang, and Hak Soo Choi. 2013. Near-
infrared fluorescence imaging for noninvasive trafficking of
scaffold degradation. Scientific Reports 3:1198.
Published Version doi:10.1038/srep01198
Accessed February 19, 2015 11:59:56 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11180467
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAANear-Infrared Fluorescence Imaging for
Noninvasive Trafficking of
Scaffold Degradation
Soon Hee Kim
1,2, Jeong Heon Lee
1, Hoon Hyun
1, Yoshitomo Ashitate
1, GwangLi Park
1, Kyle Robichaud
1,
Elaine Lunsford
1, Sang Jin Lee
3, Gilson Khang
2 & Hak Soo Choi
1
1Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School,
Boston, MA 02215,
2WCU Department of BIN Fusion Technology, Chonbuk National University, Jeonju 561-756, South Korea,
3Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC 27101.
Biodegradable scaffolds could revolutionize tissue engineering and regenerative medicine; however, in vivo
matrix degradation and tissue ingrowth processes are not fully understood. Currently a large number of
samples and animals are required to track biodegradation of implanted scaffolds, and such nonconsecutive
single-time-point information from various batches result in inaccurate conclusions. To overcome this
limitation, we developed functional biodegradable scaffolds by employing invisible near-infrared
fluorescence and followed their degradation behaviors in vitro and in vivo. Using optical fluorescence
imaging, the degradation could be quantified in real-time, while tissue ingrowth was tracked by measuring
vascularization using magnetic resonance imaging in the same animal over a month. Moreover, we
optimized the in vitro process of enzyme-based biodegradation to predict implanted scaffold behaviors in
vivo, which was closely related to the site of inoculation. This combined multimodal imaging will benefit
tissue engineers by saving time, reducing animal numbers, and offering more accurate conclusions.
T
issue engineering offers attractive approaches for the reconstruction of damaged tissues and organs. The
basic approach includes creating a neo-tissue by combining cells with biodegradable natural and/or syn-
thetic polymeric scaffolds under suitable culture conditions, resulting in a tissue construct that can be
implanted in vivo for bone, cartilage, musculoskeletal, and cardiovascular regeneration
1–3. The implanted scaf-
folds are eventually degraded and replaced by vascularized tissues over time, and the rate of scaffold degradation
and tissue formation inside the scaffold must be equivalent for successful outcomes
4,5. Many efforts have focused
on monitoring scaffold degradation behaviors by measuring changes in mechanical properties
6,7, and molecular
weight
6,8,matrixweight
9,morphology
6,viscosity
10;however,mostofthesemethodsrequiresacrificeofnumerous
animals at various time points, which often leads to inaccurateconclusions, as there can be broad batch-to-batch
and animal-to-animal variations.
To avoid these pitfalls, longitudinal monitoring of scaffold degradation and cell/tissue ingrowth using non-
invasive imaging modalities has been attempted. The feasibility of using ultrasound elasticity imaging was
demonstrated to measure mechanical properties and degradation of implanted scaffolds
11, while magnetic res-
onanceimaging(MRI)hasbeenappliedtotrackimplantedcellspre-labeledwithferumoxides
12.Real-timeoptical
fluorescence imaging techniques have also been applied for in situ monitoring of implanted biomaterials
13,14.
Most recently, Artzi et al. demonstrated noninvasive assessment of implanted hydrogels sequentially to model
hydrolytical and enzymatical degradation of biomaterials
15. However, the result from in vitro was still far from
accurate to predict in vivo biodegradation behaviors because of the physical, chemical, and optical instability of
the visible wavelength fluorophore used for the study. Also, endogenous tissue autofluorescence in the visible
wavelength range limits the use of such conventional fluorophores in vivo
16.
To overcome these limitations, we engineered biodegradable scaffolds using an invisible near-infrared (NIR)
fluorophore having excellent optical properties and high physicochemical stability in serum and in the body,
which enabled longitudinal monitoring of scaffold degradation in vivo. Moreover, the NIR fluorescence imaging
(700–900 nm) eliminates autofluorescence from the body, which can increase accuracy of imaging data from
animals
17–19. In addition, we applied noninvasive and nonirradiant MRI to assess tissue ingrowth by observing
vascularization during neo-tissue formation.
SUBJECT AREAS:
TISSUE ENGINEERING
FLUORESCENCE IMAGING
OPTICAL IMAGING
NANOSTRUCTURES
Received
29 November 2012
Accepted
18 January 2013
Published
5 February 2013
Correspondence and
requests for materials
should be addressed to
S.J.L. (sjlee@
wakehealth.edu) or
G.K. (gskhang@jbnu.
ac.kr). or H.S.C.
(hchoi@bidmc.
harvard.edu)
SCIENTIFIC REPORTS | 3 : 1198 | DOI: 10.1038/srep01198 1Results
Engineering biodegradable NIR scaffolds.The extracellular matrix
(ECM) scaffold derived from porcine small intestinal submucosa
(SIS) has been extensively characterized and used in the various
fields of tissue engineering
20–23. As shown in Fig. 1a, the NIR
fluorescent biodegradable scaffold was prepared by conjugating
ZW800-1 N-hydroxysuccinimide (NHS) ester to the collagen unit
on the crosslinked SIS scaffold. The zwitterionic NIR fluorophore
ZW800-1 presents stable physicochemical and optical properties in
collagenase buffers (Fig. 1b) as well as no measurable toxicity in
mice, rats, and pigs
17,19,24. The physical integrity of the scaffold
such as surface and cross-sectional gross morphology was
preserved after NIR fluorophore conjugation (Fig. S1). To engineer
a highly bright scaffold, various labeling ratios were demonstrated,
and the contrast-to-background ratio (CBR) was calculated by
measuring NIR fluorescence signals (see Online Methods and
Fig. S2). The highest CBR without quenching was observed when
the ratio of dye against the collagen unit was around 1 (labeling ratio
< 0.5), and we used this labeling ratio to prepare NIR scaffolds for
the rest of study (Table S1).
Quantitation of scaffold degradation in vitro. To quantify the
degree of scaffold degradation in vitro, we measured signal
reduction in the NIR scaffolds using the FLARE
TM imaging system
over a month. Since interstitial collagenase breaks down type I
collagen that is abundant in SIS scaffold (.90% protein)
20,w e
prepared various concentrated collagenase buffers (0–1 mg/mL) to
find the best condition to predict in vivo scaffold degradation. The
rate of scaffold degradation was monitored by measuring changes in
NIR fluorescence signals from the scaffold. The scaffold degradation
facilitatedproportionallytothecollagenaseconcentration(Fig.S3a),
and the NIR fluorescence signal decreased over the incubation time
(Fig.2a).Indeed,almostnoNIRsignalwasfoundfromthescaffoldat
D28 incubation in 1 mg/mL collagenase buffer. However, the shape
of scaffold was not changed significantly because the collagen-based
scaffold shows enzyme-mediated bulk erosion, and the degraded
NIR-conjugated collagen units are diffused out from the scaffold
25.
To confirm the biodegradation rate of NIR scaffolds, we collected
incubation solutions at each time point and quantitated the released
amount of dyes (Fig. S3b). The NIR scaffold incubated in phosphate
buffer without collagenase was used as a control to compensate the
ZW800-1
PBS, pH 8.0 
a.
b.
EDC
EtOH:DW = 95:5 
Collagen
Scaffold
MW = 1041 Da 
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ZW800-1
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Figure 1 | Preparation of NIR fluorophore-conjugated collagen scaffold. (a) Schematic drawing of NIR scaffold preparation and chemical structure of
ZW800-1NHSester.(b)OpticalpropertyandstabilityofZW800-1(10 mM)incollagenasebuffer.Shownareabsorbance spectrameasuredafter10-fold
dilution in working buffer (extinction coefficient 5 234,000 L mol
21 cm
21 in collagenase buffer).
www.nature.com/scientificreports
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early phase, relatively high signals were found in buffer solutions
because of rapid degradation of non-crosslinked collagen units,
which were diffused out from the collagen matrix. As summarized
in Fig. 2a, gradual signal reduction was observed in the scaffold over
28 days, while proportional signal increase was measured in the
accumulated incubation buffer. Therefore, signal reduction in the
scaffold reflects degradation of NIR-conjugated collagen units
from the scaffold.
As a gold standard for scaffold degradation measurement, we
performed a gravimetric assay that has been commonly used in the
field of tissue engineering to provide the absolute value of mass
changes in the scaffold. At least 5 samples were taken at each time
incubation point and lyophilized to measure the remaining mass. As
shown in Fig. 2b, the scaffolds in various collagenase buffers showed
a very similar degradation pattern with the result from optical fluor-
escence measurement. Using fluorescence microscopy, we con-
firmed that the cross-section of the NIR scaffold collapsed
gradually over collagenase concentrations with significant reduction
in fluorescence signals (Fig. S4). This result indicates that the fluor-
escence signal reduction corresponds to the proportional bio-
degradation of NIR scaffolds.
Quantitation of scaffold degradation in vivo. To investigate
the effect of local enzyme amount-mediated biodegradation in the
body, NIR scaffolds were implanted into the subcutaneous pocket of
axilla and thigh region separately. It is known that mechanical stress
around the implanted scaffold is a major determining factor
for the degree of the foreign body reaction
26, which stimulates
collagenase production and release from fibroblasts, macrophages,
and neutrophils
27. As shown in Fig. 3a, a significant decrease in the
NIR fluorescence signal was observed from the scaffolds over the
implantation time. Because ZW800-1 is stable in collagenase buffer
(Fig. 1b) as well as in the body
17, the signal reduction corresponds to
the biodegraded collagen units by the enzyme (see Fig. 5b). The
degree of signal reduction was notably enhanced in the axilla site
comparedtothethighregion.Thepatternofsignalreductioninboth
regions was similar to those from the in vitro test incubated with
different collagenase concentrations: 0.5 mg/mL collagenase for
axillascaffoldand0.1 mg/mLcollagenaseforthighscaffold(Fig.3b).
Noninvasive magnetic resonance imaging. MRI was used to
confirm the tissue infiltration process into the scaffold by
measuring vascular formation over 28 days in the same animal. As
shown in Fig. 4a, T1-weighted MRI without contrast agent reveals
little to no evidence of vasculature within the implanted scaffold as
evidenced by distinct fat and tissue separation between native and
implanted region (arrowheads). By administrating Magnevist, the
Figure 2 | Quantification of in vitro scaffold degradation in collagenase
buffers. (a) Optical measurement of NIR fluorophores in scaffolds (black
symbols, solid lines) and in the released solutions (white symbols, dotted
lines).(b)Conventionalscaffolddegradationprofilesbymeasuringweight
loss. &,% 5 0.01 mg/mL;.,# 5 0.1 mg/mL;¤,e 5 0.5 mg/mL
collagenase.Theweightwasmeasuredafterdryingscaffoldscompletelyfor
2 days. Each data point is the mean 6 S.D. from N 5 5 scaffolds.
Figure 3 | Quantification of in vivo scaffold degradation in nude mice.
(a) Optical measurements of scaffold degradation by imaging NIR
fluorescenceovertheskin.A,axilla;C,control;T,thigh.(b)Timecourseof
signal changes in NIR scaffolds in animals (solid lines). In vitro test results
were added as dotted lines for comparison.. 5 0.1 mg/mL;
¤50.5 mg/mLcollagenase.Eachdatapointisthemean6S.D.fromN5
5 scaffolds. Scale bars 5 1 cm.
www.nature.com/scientificreports
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scaffold, which suggests onset of vascularization within and around
scaffold borders. MR images of the axilla site exhibit bright and
homogenous signals throughout the implanted scaffold at 28 days
post-implantation due to the fully vascularized tissue. Neovascular
formation in the thigh region was slower than the axillary pocket,
corresponding to the slow degradation of the implanted scaffold.
Histological analysis using NIR fluorescence microscopy. In order
to evaluate tissue ingrowth and inflammatory response of the tissue
within the scaffold, the extracted scaffolds at each time point were
observed through a NIR fluorescence microscopy after staining with
hematoxylin and eosin (H&E). As shown in Fig. 4b, the size of the
retrieved scaffolds was reduced over the implantation time, and the
NIR fluorescence signal decreased along with the smaller scaffold.
When compared to the scaffolds at the thigh region, those from the
axilla were smaller in size because of faster biodegradation by
enzymes and active movement
28. Some inflammatory cells such
as polymorphonuclear cells, monocytes, and macrophages were
observed around the scaffold, and the proliferating fibroblasts in
granulation tissue have been recruited and deposited into the
scaffold
27 (Figs. 4c and S5). The host tissue infiltration into the
scaffold facilitated scaffold degradation and consequentially
reduced signal intensity. Tissue infiltration in the axilla scaffold
was faster than those from the thigh region, which is consistent
with the fluorescence and MR images.
In vivo biodistribution and clearance. To determine the bio-
distribution and clearance of degraded collagen units from the NIR
scaffold in the body, whole-body optical imaging was performed
using the FLARE
TM imaging system. As shown in Fig. 5a, the
biodegraded scaffold was found mainly in the kidneys and bladder.
The NIR fluorescence signal decreased over the period of
implantation time, and only a small amount of signal was observed
a.
b.
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Figure 4 | Quantification of tissue ingrowth and scaffold degradation. (a) In vivo MR imaging of NIR scaffold implants with and without
Magnevist. Arrowheads 5 implantation sites. (b) NIR fluorescence imaging of resected scaffolds at each time point. A, axilla; C, control; T, thigh.
(c) H&E and NIR imaging of resected scaffolds from (b). Scaffold degradation accompanying tissue ingrowth was compared. Scale bars 5 1 cm for
(a) and (b), and 100mm for (c).
www.nature.com/scientificreports
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demonstrates that the NIR scaffold could be removed completely
from the body after it has performed its mechanical supporter
function during tissue ingrowth. To investigate whether the NIR
signal is from the degraded fluorophore or from the conjugated
scaffold unit, in vitro incubation media and in vivo urine samples
were collected at various time points, and the molecular weight
difference was measured using MALDI-TOF MS spectrometry
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Figure 5 | Optical imaging and MALDI-TOF analysis of biodegraded scaffold over time. (a) Biodistribution and clearance of released NIR-scaffold
units from the implantation site. Abbreviations used are: Bl, bladder; In, intestine; Ki, kidney; Li, liver; Pa, pancreas; Sp, spleen. Shown are color
image,NIRfluorescenceimage,andapseudo-colormergedimageofthetwo.Scalebars51 cm.(b)MALDI-TOFanalysisofdegradedscaffoldinbuffers
and urine. Samples were filtered by a desalting microcolumn, packed with porous R2 resin before the measurement.
www.nature.com/scientificreports
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conjugation incubated for 1 day in 0.5 mg/mL collagenase buffer
showed multiple monomeric collagen-like structures around m/z
of 14,930, while the fluorophore-conjugated scaffold showed
higher molecular weights consistently in the in vitro degradation
media and in the urine sample. An NIR scaffold incubated in
collagenase-free buffer showed no peak in the range of 2,000 to
30,000 Da, which means no enzyme-mediated degradation happens
without collagenase. To confirm whether ZW800-1 solely degraded
in buffers and urine, a lower mass range (50–2,500 Da) was also
scanned using MALDI-TOF (Fig. S6). Because ZW800-1 is highly
stable in collagenase buffer (Fig. 1b; . 98%, 24 h), only the intact
molecular mass of dye was detected by MALDI-TOF at 1 day post-
incubation. On the other hand, none of the degraded ZW800-1 peak
was observed from NIR scaffolds in buffers or in urine samples at the
lower mass range.
Discussion
Although biodegradable scaffolds have been successfully used for
tissueengineeringandregenerativemedicineinhumans,thedetailed
process for scaffold degradation and tissue formation is not fully
understood. Conventional techniques for measuring scaffold degra-
dationrequirealargenumberofsamplesandanimalstobesacrificed
at every single time point, thus resulting in an inaccurate conclusion
because of nonsequential measurements from different samples.
Noninvasive imaging techniques such as ultrasound elasticity
imaging (UEI)
11 and MRI
12 have been developed to monitor longit-
udinal tissue growth; however, these imaging modalities cannot pro-
vide direct evidence of matrix degradation.
WhencombinedwithMRI,opticalfluorescenceimagingusingthe
NIR wavelength can be one of the solutions for monitoring scaffold
degradation continuously along with tissue development. By tagging
an invisible fluorophore covalently to the biodegradable scaffold, the
degradation behavior of various biomaterials could be monitored in
real time. Since light scattering and absorption in human tissue are
the major obstacles in optical fluorescence imaging, NIR wavelength
(700–900 nm) can efficiently minimize tissue autofluorescence,
resulting in less background interference and enhanced signal-to-
background ratio
29–32.
Another caveat in the tissue engineering and regenerative medi-
cine field is that no optimum in vitro biodegradation condition has
been reported yet to predict the enzyme-mediated scaffold degrada-
tionandtissueformationinthebody.AlthoughArtzietal.reporteda
fluorescence imaging-based trafficking method to follow the erosion
behavior of hydrogels and scaffolds in various conditions
15, specific
formulaswererequiredtocompensatethedifferencebetweeninvitro
and in vivo results. We could successfully overcome this problem by
using direct comparison of NIR fluorescence imaging and quantita-
tion of actual degradation in scaffolds and media simultaneously in
variouscollagenasebuffers.Indeed,wefoundthattherateofscaffold
degradation and tissue ingrowth was closely related to the implanta-
tion site because of the natural variation of enzyme content and
mechanical movement.
The question still remains as to whether optical fluorescence
imaging can be used to track both scaffold degradation and tissue
ingrowth simultaneously and quantitatively over the period of com-
plete regeneration. Using dual-channel NIR wavelengths such as
700 nm and 800 nm, one color can be used to follow the fate of
the scaffold and the other to follow the growth of tissue in the body.
Although this technique has been extensively applied in image-
guided surgery, current fluorescence imaging is limited by the low
penetration and resolution of light up to several millimeters
29,30.
Diffuse optical tomography and photoacoustic tomography are
actively investigated in the imaging field to overcome this limitation
for deep tissue imaging. Another solution is the use of multimodal
imaging techniques using NIR fluorophore-tagged scaffolds and
pre-labeled stem cells or primary cells for combined MRI, CT or
bioluminescence imaging to follow neo-tissue formation along with
matrix degradation. In any case, NIR fluorescence imaging will play
a key role in trafficking the fate of implanted materials in the body,
which will initiate a new era of tissue engineering and regenerative
medicine.
Methods
Engineering NIR fluorescent scaffolds. The biodegradable scaffold using porcine
small intestinal submucosa (SIS) was prepared as previously reported
20,22 (also see
Supplementary Methods). An 800 nm NIR fluorescence emitting ZW800-1
17 was
conjugated on the scaffold using conventional N-hydroxysuccinimide (NHS) ester
chemistry in phosphate buffer at pH 8.0. After rinsing the unconjugated dyes in
distilled water 5 times, the washing solutions were collected to calculate the final
labeling ratio (lmax at 770 nm, extinction coefficient 5 246,000 L mol
21 cm
21 in
PBS). As shown in Table S1, the final quantity of ZW800-1 on the scaffold was
calculated by subtracting the unconjugated free dyes from the washing solutions.
Invitroscaffolddegradationmeasurements.TheNIRscaffolds(1.4 cmdiameter3
0.8 cm height) were placed in 20 mL vials containing 5 mL collagenase (collagenase
Type I, MP Biomedicals, LLC, OH) in PBS, pH 7.4. These vials were incubated on a
shakertablesetat50 rpmand37uCforvarioustimeperiodsofupto4weeks.At3-day
intervals,theentiremediawastakenfordegradationanalysisandreplacedwith5 mL
offreshcollagenasesolution.Forscaffoldimaging,NIRscaffoldswerewashed5times
in distilled water and imaged in fresh solutions using the FLARE imaging system.
Solutionsusedforscaffold washingwereaddedtothemeasurement. TheNIRimages
were normalized and the signal intensity was quantified using ImageJ software
(ver. 1.45q). The dye quantity released from the scaffold was measured using a
fluorospectrometer at 770 nm excitation and 790 nm emission. The degradation
patternwasplottedasaccumulated-releaseprofileoverthetimecourseof4weeks.At
each time point, at least 5 scaffolds were collected to measure the mass loss after
freeze-drying for 2 days. Mass loss was calculated using the following equation:
W1/W0 3 100 (%), where W0 indicates the original scaffold weight and W1 means
degraded scaffold weight after lyophilization.
Animal models for scaffold implantation. Animals were housed in an AAALAC-
certifiedfacility, andall animalstudieswereperformedunder thesupervision ofBeth
Israel Deaconess Medical Center’s Institutional Animal Care and Use Committee
(IACUC) in accordance with approved institutional protocol #155-2008. NCRNU
nudemice(20–30 g,6–8weeks) werepurchasedfrom TaconicFarms(Germantown,
NY). Prior to transplant scaffolds, mice were anesthetized with an intraperitoneal
injection of ketamine (100 mg/kg) and xylazine (10 mg/kg). NIR scaffolds
pre-wetted with Matrigel (BD Bioscience, Bedford, MA) were implanted into the
subcutaneous pocket of axilla and thigh region, respectively. An unconjugated
scaffold (control) was also transplanted in the middle of 2 NIR scaffold sites to retain
space among scaffolds. Noninvasive optical imaging was performed from the same
animal every 3 days using the FLARE imaging system. One animal at each time point
was sacrificed to quantify the biodistribution of the degraded scaffolds, and the
implanted constructs were harvested to use for histological analysis after H&E
staining (see below).
NIR fluorescence microscopy. For microscopic imaging, scaffolds were collected
andextractedfrominvitroandinvivostudy,fixedin4%formalinfor10 min,molded
with Tissue-Tek OCT compound (Fisher Scientific, Pittsburgh, PA), and frozen in
liquidnitrogen.Frozensectionswerecuttoa20 mmthickness,andtheirstructureand
degradation pattern were examined by a 4-channel fluorescence microscope (see
Supplementary Methods).
Optical imaging system and quantification. The real-time intraoperative FLARE
TM
imaging system has been described in detail previously
33,34. In this study, a custom
filter set (Chroma Technology Corporation, Brattleboro, VT) composed of a
750 6 25 nm excitation filter, a 785 nm dichroic mirror, and an 810 6 20 nm
emission filter, with white light (400 to 650 nm) at 40,000 lx were used to detect NIR
fluorescence signals. Color and NIR fluorescence images were acquired
simultaneouslywithcustomsoftwareatratesupto15 Hzovera15 cmdiameterfield
of view. A pseudo-colored green was used for NIR fluorescence in the color-NIR
merged images. At each time point, the fluorescence (FL) and background (BG)
intensity of a region of interest (ROI) over each organ/tissue was quantified using
ImageJ software. The contrast-to-background ratio (CBR) was calculated as
CBR 5 FL/BG 2 1. To quantify dye contents in the scaffold and from the released
solution, NIR scaffolds in collagenase-free buffers were used as a control, and the
signal changes were applied to the final quantification. For scaffold-implanted
animals, the CBR was measured using an ROI over the scaffold for FL and an ROI
over the skin for BG
35. At least 5 animals were analyzed at each time point. Statistical
analysis was carried out using a one-way ANOVA followed by Tukey’s multiple
comparisons test. Results were presented as mean 6 S.D. and curve fitting was
performed using Prism version 4.0a software (GraphPad, San Diego, CA).
Magneticresonanceimaging(MRI).Toconfirmtissueformationinthescaffold,1T
micro MRI system (Aspect, Israel) was used. 50 mL of Magnevist (Berlex Imaging,
www.nature.com/scientificreports
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formation by vascularization. The imaging protocol consisted of T1-weighted spin
echo sequence with TR/TE 5 412.6/10.9 ms, matrix size 5 256 3 256,
slice thickness 5 2.0 mm, gap 5 0.0 mm, field of view 5 60 mm.
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